在患有耳神经无形成或低形成的儿科患者中进行耳植入的临床前景
Ava Raynor1, Sara Perez2, Megan Worthington2
1Children's Hospital of Philadelphia, 3401 Civic Center Blvd, Philadelphia, PA 19104, USA.
Audiology research
|August 27, 2025
概括
美国的听力专业人员通常更喜欢对有耳神经缺陷 (CND) 的儿童进行耳植入 (CI). 然而,
科学领域:
- 耳鼻喉科
- 听力学
- 儿童医学
背景情况:
- 儿童耳神经缺陷的耳植入 (CI) 是由于患者的变化和不一致的指导方针而引起的争论.
- 目前在美国对患有CND的儿童的CI候选药物的做法尚不清楚.
研究的目的:
- 评估美国听力保健专业人员对患有CND的儿童的CI候选者的看法.
- 了解当前的做法,包括成像和结果预期,用于CI与听觉脑干植入物 (ABI) 在儿科CND病例中.
主要方法:
- 在全国范围内向CI临床医生分发了一项匿名在线调查,包含19个问题.
- 调查数据包括专业背景,耳无形成/无形成的经验,以及对CI/ABI候选人的看法.
- 分析了多选项和开放式的反应.
主要成果:
- 大多数临床医生支持低成形 (60. 2%) 和无成形 (41. 7%),听力学家比神经病学家更有可能支持CI.
- 偏好CI而不是ABI的原因包括风险较低,可访问性和潜在的好处.
- 一个个案例的方法,整合成像,电生理学和咨询,强调,但只有22.2%的人认为结构因素是成功的关键预测因素.
结论:
- 尽管有诊断工具的局限性,但美国听力保健专业人士普遍支持CI作为儿科CND的主要选择.
- 对于儿科无形成症和低形成症的临床前景存在显著的差异,表明缺乏共识.
- 需要标准化的评估和成像方案来提高一致性,并制定基于证据的指导方针.
相关概念视频
01:19Clinical Applications of Epidermal Stem Cells
2.4K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.4K
01:24Tissue Transplantation
1.4K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
692
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
692
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
967
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
554
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
408
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408